MAB'Solut Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
MAB'Solut General Information
Description
Developer of monoclonal antibodies. The company is engaged in the research and development of immune antibodies for the treatment of ophthalmic diseases, cancers, autoimmune and inflammatory diseases.
Contact Information
Website
www.mabsolut.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
MABSolys
Primary Office
- Génopole Campus 1
- 5 rue Henri Desbruères
- 91030 Evry Cedex
- France
MAB'Solut Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MAB'Solut Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Thierry Guyon Ph.D | Head, Laboratories |
MAB'Solut Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|